Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04843319 |
Title | To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (VERU-100) |
Acronym | VERU-100 |
Recruitment | Terminated |
Gender | male |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Veru Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |